Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.

Ketesse injection

Marketed by Ferron Par Pharmaceuticals

Ingredients in every ml

Dexketoprofen 25 mg

Each package contains

5 ampoules of 2 ml

Dosage form

injection

Dosage formInjection

Flavour

None

W.H.O. classification

N02B
N02B

A.T.C. Level 1

Anatomical Main group

N - Nervous system
N02B

A.T.C. Level 2

Therapeutic subgroup

N02 - Analgesics
N02B

A.T.C. Level 3

Pharmacological subgroup

N02B - Other Analgesics and Antipyretics in ATC

Available in

Indonesia

Warnings

Alcohol

CAUTIONThis item may not be safe for use with alcohol. Use with caution and after consultation with your doctor.

Machinery

NOT RECOMMENDEDThis item should not be used while operating heavy machinery.

Pregnancy

NOT RECOMMENDEDThis item is not safe for use during pregnancy.

Lactation

NOT RECOMMENDEDThis item is not safe for use during lactation.

Indication

Pain symptoms of acute intensity
Symptomatic treatment of acute pain when oral administration is not appropriate, such as postoperative pain. (IPHA p.2, Medscape p.1, PI Ketesse, Product Monograph-2 p.70, Product Profile Injection p.89, SPC p.1)

Dosage

UP TO 18 YEARS
The safety and efficacy Ketesse in children have not been established and the product should not be used in children.

Ketesse® is not for long period usage, and the therapy should be limited for acute symptomatic period

18 YEARS OLD AND ABOVE
The recommended dose is 50 mg every 8-12 hours. Repeated every 6 hours if necessary. Total daily dose should not exceed 150 mg.

Ketesse® is not for long period usage, and the therapy should be limited for acute symptomatic period

POSTOPERATIVE PAIN
Ketesse® can be used with opioid analgesic to overcome the pain, especially in the initial period after surgery when the pain is more painful.